Offering some relief for people suffering from prostate cancer, Starpharma (ASX: SPL) might be on the verge of a breakthrough as it announced that its drug DEP® cabazitaxel has shown promising anti-tumour activity data at the European Society of Medical Oncology (ESMO) Congress in Paris, France. The new data from its phase 2 trial reveals
Read More
Having tripled their network of allied healthcare businesses since listing on the ASX four years ago to now be operating 309 businesses, Healthia (ASX: HLA) is on the move again with institutional investors keen for a bigger slice of the pie by backing the company with $10 million to accelerate its growth. The $10 million
Read More
If you have fever dreams about felons escaping prison and breaking into your home, peaceful nights lay ahead as Government-backed venture builder Strategic Elements (ASX: SOR) has signed an agreement with software industrial company Honeywell to deploy automation and robotics Company Stealth Technologies’ Autonomous Security Vehicles (ASVs) for perimeter security. Stealth will engage exclusively with
Read More
The North American sports betting industry continues to scale to new highs as punters in Maryland have now gained access to sports betting with PointsBet (ASX: PBH), which continues its national expansion. Punters from Maryland have recently seen a considerable change in their access to retail sports betting following new legislation signed by Maryland Gov.
Read More
After the Human Research Ethics Committee (HREC) rejected the Company’s flagship drug, EmtinB, knocking back years of research in the process, disappointed CEO and Managing Director, Mr Matt Liddelow, announced that he is resigning from his position immediately. Liddelow noted, “I acknowledge the loss in shareholder value as a result of the rejected Human Research
Read More
What do you do when you lose nearly $100 million in only six months? Re-evaluate everything. That’s exactly what defence, space and communications company Electro Optic Systems (ASX: EOS) is doing as it expresses disappointment in its first half result, losing $98.9 million in six months ending June 30, 2022. The loss is even more
Read More
Conventional property settlement is daunting for some of us. Having to go back and forth to lawyers, conveyancers, and financial institution offices during lunch breaks is rather time consuming and stressful. As the world progresses to the digital era, PEXA (ASX: PXA) has been facilitating 80% of modern property exchanges in Australia by creating a
Read More
The board of digital payments company Tyro Payments (ASX: TYR) has politely rejected a $658 million takeover bid from Potentia Capital Management and its consortium, where the unsolicited offer values the Group at $1.27 per share, a 30% premium above yesterday’s close price of $0.985. The tech-focussed consortium comprises HarbourVest Partners, MLC Investments and the
Read More
Before there was Covid-19, viruses like Zika were baffling the medical community and the world, of course. Today, the Zika virus market is worth approximately US$17 billion; yet, it has no treatment. Hopefully, that may not be the case for long as life-sciences company Invion (ASX: IVX) has announced that its patented tech PhotosoftTM has
Read More
If you’ve been following the war in Ukraine, one thing that the greater world has woken up to is the difference high-intelligence technology makes. The use of video communications for real-time targeting and troop movements by the undermanned Ukrainians has been astonishing. Looking to assist in this area (not for Ukraine), communications tech company Harvest
Read More
